| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 115.5 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 115.5. The average price that BIM.PA shares were previous bought at was EUR 108.661. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in BIM.PA has increased by EUR 25,971 (USD $29,534) compared to the previous valuation of BioMerieux however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 42.9 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 42.9. The average price that FME.DE shares were previous bought at was EUR 44.2419. The current market price is -3.0% lower than average price they were purchased at. The value of the holding in FME.DE has increased by EUR 44,102 (USD $50,152) compared to the previous valuation of Fresenius Medical Care AG however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| ZEAL.CO - | HOLD | 0 @ DKK 56.3251 | DKK 0 | The current share valuation price of ZEAL.CO based on adjusted close was DKK 56.3251. The average price that ZEAL.CO shares were previous bought at was DKK 81.219. The current market price is -30.7% lower than average price they were purchased at. The value of the holding in ZEAL.CO has fallen by DKK 18,474 (USD $2,814) compared to the previous valuation of |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 53.86 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 53.86. The average price that ERF.PA shares were previous bought at was EUR 49.0647. The current market price is 9.8% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 23,094 (USD $26,262) compared to the previous valuation of Eurofins Scientific SE |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 227.3 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 227.3. The average price that SRT3.DE shares were previous bought at was EUR 221.961. The current market price is 2.4% higher than average price they were purchased at. The value of the holding in SRT3.DE has fallen by EUR 32,367 (USD $36,807) compared to the previous valuation of Sartorius AG |
| SOBI.ST - | HOLD | 0 @ SEK 25.2162 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 25.2162. The average price that SOBI.ST shares were previous bought at was SEK 26.8142. The current market price is -6.0% lower than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 6,040 (USD $628) compared to the previous valuation of |
| GALD.SW - | HOLD | 0 @ CHF 98.8549 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 98.8549. The average price that GALD.SW shares were previous bought at was CHF 96.9381. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 142,749 (USD $172,248) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 201.2 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 201.2. The average price that DIM.PA shares were previous bought at was EUR 187.837. The current market price is 7.1% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 1,390 (USD $1,581) compared to the previous valuation of Sartorius Stedim Biotech |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 49.46 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 49.46. The average price that REC.MI shares were previous bought at was EUR 52.5394. The current market price is -5.9% lower than average price they were purchased at. The value of the holding in REC.MI has increased by EUR 13,199 (USD $15,010) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 54.3 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 54.3. The average price that ORNBV.HE shares were previous bought at was EUR 47.9545. The current market price is 13.2% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 38,615 (USD $43,913) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| RO.SW - | HOLD | 0 @ CHF 295.982 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 295.982. The average price that RO.SW shares were previous bought at was CHF 304.565. The current market price is -2.8% lower than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 23,367 (USD $28,196) compared to the previous valuation of |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 97.7 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 97.7. The average price that IPN.PA shares were previous bought at was EUR 108.377. The current market price is -9.9% lower than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 11,728 (USD $13,337) compared to the previous valuation of Ipsen SA |
| HIK.L - | HOLD | 0 @ GBP 22.2306 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 22.2306. The average price that HIK.L shares were previous bought at was GBP 24.382. The current market price is -8.8% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 21,417 (USD $28,541) compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 31.2635 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 31.2635. The average price that DEMANT.CO shares were previous bought at was DKK 34.3207. The current market price is -8.9% lower than average price they were purchased at. The value of the holding in DEMANT.CO has increased by DKK 14,863 (USD $2,264) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 8.514 | EUR 0 | |
| AMP.MI - Amplifon SpA | HOLD | 0 @ EUR 16.935 | EUR 0 | The current share valuation price of AMP.MI based on adjusted close was EUR 16.935. The average price that AMP.MI shares were previous bought at was EUR 23.0876. The current market price is -26.6% lower than average price they were purchased at. The value of the holding in AMP.MI has fallen by EUR 6,896 (USD $7,842) compared to the previous valuation of Amplifon SpA |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 54.048 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 54.048. The average price that NOVO-B.CO shares were previous bought at was DKK 69.9097. The current market price is -22.7% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 1,349,600 (USD $205,556) compared to the previous valuation of Novo Nordisk A/S |
| COLO-B.CO - | HOLD | 0 @ DKK 97.1391 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 97.1391. The average price that COLO-B.CO shares were previous bought at was DKK 98.8373. The current market price is -1.7% lower than average price they were purchased at. The value of the holding in COLO-B.CO has increased by DKK 83,602 (USD $12,733) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 37.02 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 37.02. The average price that QIA.DE shares were previous bought at was EUR 36.5924. The current market price is 1.2% higher than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 60,689 (USD $69,015) compared to the previous valuation of QIAGEN NV |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.41919 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.41919. The average price that HLN.L shares were previous bought at was GBP 4.66661. The current market price is -5.3% lower than average price they were purchased at. The value of the holding in HLN.L has increased by GBP 45,063 (USD $60,052) compared to the previous valuation of Haleon PLC however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 22.99 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 22.99. The average price that BAYN.DE shares were previous bought at was EUR 21.0708. The current market price is 9.1% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 237,807 (USD $270,432) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 98.1023 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 98.1023. The average price that NOVN.SW shares were previous bought at was CHF 97.7507. The current market price is 0.4% higher than average price they were purchased at. The value of the holding in NOVN.SW has increased by CHF 255,767 (USD $308,622) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 121.747 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 121.747. The average price that AZN.L shares were previous bought at was GBP 129.901. The current market price is -6.3% lower than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 380,064 (USD $506,482) compared to the previous valuation of AstraZeneca PLC |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 92.36 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 92.36. The average price that SAN.PA shares were previous bought at was EUR 97.4161. The current market price is -5.2% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 534,148 (USD $607,428) compared to the previous valuation of Sanofi SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 16.2603 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 16.2603. The average price that GSK.L shares were previous bought at was GBP 16.7052. The current market price is -2.7% lower than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 115,507 (USD $153,927) compared to the previous valuation of GlaxoSmithKline PLC |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 253.3 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 253.3. The average price that EL.PA shares were previous bought at was EUR 249.877. The current market price is 1.4% higher than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 183,489 (USD $208,662) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 608.289 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 608.289. The average price that LONN.SW shares were previous bought at was CHF 575.623. The current market price is 5.7% higher than average price they were purchased at. The value of the holding in LONN.SW has increased by CHF 184,023 (USD $222,052) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| ALC.SW - | HOLD | 0 @ CHF 83.2396 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 83.2396. The average price that ALC.SW shares were previous bought at was CHF 82.6482. The current market price is 0.7% higher than average price they were purchased at. The value of the holding in ALC.SW has increased by CHF 171,488 (USD $206,926) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 535.8 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 535.8. The average price that ARGX.BR shares were previous bought at was EUR 572.549. The current market price is -6.4% lower than average price they were purchased at. The value of the holding in ARGX.BR has increased by EUR 120,368 (USD $136,881) compared to the previous valuation of Argenx SE however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 149.7 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 149.7. The average price that UCB.BR shares were previous bought at was EUR 176.904. The current market price is -15.4% lower than average price they were purchased at. The value of the holding in UCB.BR has increased by EUR 141,040 (USD $160,389) compared to the previous valuation of UCB SA however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| ROG.SW - | HOLD | 0 @ CHF 277.642 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 277.642. The average price that ROG.SW shares were previous bought at was CHF 287.977. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 425,710 (USD $513,683) compared to the previous valuation of |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 22.06 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 22.06. The average price that PHIA.AS shares were previous bought at was EUR 24.0301. The current market price is -8.2% lower than average price they were purchased at. The value of the holding in PHIA.AS has increased by EUR 151,674 (USD $172,482) compared to the previous valuation of Koninklijke Philips NV however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 121.15 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 121.15. The average price that MRK.DE shares were previous bought at was EUR 134.996. The current market price is -10.3% lower than average price they were purchased at. The value of the holding in MRK.DE has increased by EUR 85,864 (USD $97,644) compared to the previous valuation of Merck KGaA however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| SDZ.SW - | HOLD | 0 @ CHF 37.0931 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 37.0931. The average price that SDZ.SW shares were previous bought at was CHF 39.4518. The current market price is -6.0% lower than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 222,165 (USD $268,076) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 265.981 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 265.981. The average price that SOON.SW shares were previous bought at was CHF 298.317. The current market price is -10.8% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 39,232 (USD $47,339) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 46.84 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 46.84. The average price that SHL.DE shares were previous bought at was EUR 50.8815. The current market price is -7.9% lower than average price they were purchased at. The value of the holding in SHL.DE has increased by EUR 127,817 (USD $145,352) compared to the previous valuation of Siemens Healthineers AG however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 39.85 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 39.85. The average price that FRE.DE shares were previous bought at was EUR 35.9767. The current market price is 10.8% higher than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Fresenius SE & Co KGaA however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| GMAB.CO - | HOLD | 0 @ DKK 180.428 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 180.428. The average price that GMAB.CO shares were previous bought at was DKK 194.212. The current market price is -7.1% lower than average price they were purchased at. The value of the holding in GMAB.CO has increased by DKK 28,156 (USD $4,288) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| STMN.SW - | HOLD | 0 @ CHF 108.025 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 108.025. The average price that STMN.SW shares were previous bought at was CHF 119.697. The current market price is -9.8% lower than average price they were purchased at. The value of the holding in STMN.SW has increased by CHF 21,903 (USD $26,429) compared to the previous valuation of however if the holding was sold on 2025-04-25 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 11.6058 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 11.6058. The average price that SN.L shares were previous bought at was GBP 12.7655. The current market price is -9.1% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 60,641 (USD $80,812) compared to the previous valuation of Smith & Nephew PLC |
| DIA.MI - DiaSorin SpA | SELL | -740 @ EUR 99.04 | EUR -73,290 | The ETF sold 740 shares of DIA.MI on 2025-04-25. The shares were previously bought for an average price of EUR 64.2316. The DiaSorin SpA shares were sold for 54.2% higher than average price of previous purchases. This sale made a profit of EUR 25,758 (USD $29,292) The average price that the ETF previously sold DIA.MI share for is EUR 98.8404 so the ETF has sold 740 shares on 2025-04-25 at a higher price than the previous selling average. |